| Subject: | Nationwide Recall of Single Lot of Hydromorphone HCl 2 mg Tablets |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 26 Dec 2008 - 01:00 pm |
| Audience: Pharmacists, consumers, primary care healthcare professionals ETHEX and FDA have notified heathcare professionals of a nationwide recall of a single lot (Lot 90219, Exp: 3/2010; NDC 58177-0620-04), of Hydromorphone HCl 2 mg Tablets due to a potential for oversized tablets. The recalled tablets are a blue, round tablet with a script "E" on one side and a "2" on the other side. If an individual were to take a higher than expected dose of Hydromorphone, the... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
